Enanta Pharmaceuticals (ENTA) said Thursday it entered into an at-the-market offering agreement under which it may offer and sell up to $75 million of its common stock from time to time.
The company said it has no obligation to sell any shares under the agreement.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.